Phep, an amino acid permease of staphylococcus aureus
Details for Australian Patent Application No. 2005238265 (hide)
International Classifications
Event Publications
9 November 2006 PCT application entered the National Phase
PCT publication WO2005/105845 Priority application(s): WO2005/105845
19 April 2007 Assignment before Grant
University of Sheffield The application has been assigned to Absynth Biologics Ltd
18 August 2011 Application Accepted
Published as AU-B-2005238265
15 December 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005238270-Morpholinylanilinoquinazoline derivatives for use as antiviral agents
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser